New gel keeps eyes safe during cataract surgery, study finds

NCT ID NCT07343973

Completed Disease control Sponsor: i+Med S.Coop. Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested OpHLINE, a clear gel used during cataract surgery to keep the eye stable and protect delicate cells. Researchers followed 69 adults who had cataract surgery with the gel. The gel worked well in most cases, and serious complications were rare. The results support OpHLINE as a reliable tool for surgeons.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: OpHLINE ophthalmic viscosurgical device (sodium hyaluronate gel)
What this could lead to: If successful, this study confirms that OpHLINE is a safe and effective tool for cataract surgery, helping surgeons protect the eye during the procedure.
What could go wrong: This is a small, completed post-market study with no control group, so results may not apply to all patients or surgical settings. The gel is already approved, so no major new breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CATARACT are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cataract

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CATARACT SURGERY

Contacts and locations

Show contact details

Locations

Araba University Hospital

Vitoria-Gasteiz, Álava, 01009, Spain
Basurto University Hospital

Bilbao, Bizkaia, 48013, Spain

More trials for these conditions

Other studies related to the condition(s) this trial covers.